1.
Neuhaus T, Luyken J, Stier S. Discontinuation of the Tyrosine Kinase Inhibitor Sunitinib in Patients with Metastatic Renal Cell Carcinoma: A Case Series. Urol J [Internet]. 2014 May 6 [cited 2024 May 8];11(2):1494-8. Available from: https://journals.sbmu.ac.ir/urolj/index.php/uj/article/view/1672